Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan added to usual care for systemic sclerosis with digital ulcers
NL-OMON45095Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bosentan in systemic sclerosis (SSc) (3 arms), sponsored by University Medical Center Groningen. Primary endpoint: Mean of right and left carotid-femoral pulse wave velocity. Started Jun 2015; status: active, not recruiting.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NL-OMON45095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45095.